Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Reo Yoshikawa"'
1
Akademický článek
Daily Physical Activity Assessed by a Triaxial Accelerometer Is Beneficially Associated with Waist Circumference, Serum Triglycerides, and Insulin Resistance in Japanese Patients with Prediabetes or Untreated Early Type 2 Diabetes
Autor: Hidetaka Hamasaki, Mitsuhiko Noda, Sumie Moriyama, Reo Yoshikawa, Hisayuki Katsuyama, Akahito Sako, Shuichi Mishima, Masafumi Kakei, Osamu Ezaki, Hidekatsu Yanai
Publikováno v: Journal of Diabetes Research, Vol 2015 (2015)
Aim. To investigate the association between daily physical activity and metabolic risk factors in Japanese adults with prediabetes or untreated early type 2 diabetes (T2D). Methods. Daily physical activity level was measured using a triaxial accelero
Externí odkaz: https://doaj.org/article/bcbc6c6dff3c41f3a4ae9843492957e9
Zobrazit plný text záznamu
2
Associations of Pericardial Fat Area Determined by Routine Chest Computed Tomography With Coronary Risk Factors and Coronary Artery Disease
Autor: Hidekatsu Yanai, Sumie Moriyama, Reo Yoshikawa, Narihiro Furugaki
Publikováno v: Journal of Clinical Medicine Research
Background: Pericardial fat has been reported to be associated with coronary risk factors and severity of coronary arterial lesions. Previous studies had measured pericardial fat volume (PFV) by using contrast-enhanced cardiac computed tomography (CT
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c399313816b097e548b7d24a476a4694
https://pubmed.ncbi.nlm.nih.gov/30937120
Zobrazit plný text záznamu
3
Sodium-Glucose Cotransporter 2 Inhibitors: Possible Anti-Atherosclerotic Effects Beyond Glucose Lowering
Autor: Sumie Moriyama, Hidetaka Hamasaki, Akahito Sako, Hidekatsu Yanai, Reo Yoshikawa, Hiroki Adachi, Hisayuki Katsuyama
Publikováno v: Journal of Clinical Medicine Research
The new drug for type 2 diabetes, the sodium-glucose cotransporter 2 (SGLT-2) inhibitor, is reversible inhibitor of SGLT-2, leading to reduction of renal glucose reabsorption and decrease of plasma glucose, in an insulin-independent manner. In additi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf95d6aee2fb4cea5b923e8f53434bd
https://doi.org/10.14740/jocmr2385w
Zobrazit plný text záznamu
6
Daily Physical Activity Assessed by a Triaxial Accelerometer Is Beneficially Associated with Waist Circumference, Serum Triglycerides, and Insulin Resistance in Japanese Patients with Prediabetes or Untreated Early Type 2 Diabetes
Autor: Hisayuki Katsuyama, Mitsuhiko Noda, Shuichi Mishima, Akahito Sako, Hidetaka Hamasaki, Reo Yoshikawa, Masafumi Kakei, Hidekatsu Yanai, Osamu Ezaki, Sumie Moriyama
Publikováno v: Journal of Diabetes Research
Journal of Diabetes Research, Vol 2015 (2015)
Aim. To investigate the association between daily physical activity and metabolic risk factors in Japanese adults with prediabetes or untreated early type 2 diabetes (T2D).Methods. Daily physical activity level was measured using a triaxial accelerom
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a004e448525496dbe9a21c33d08dafa5
Zobrazit plný text záznamu
7
Agranulocytosis due to an α-glucosidase inhibitor, voglibose
Autor: Hiroshi Kaneko, Hidekatsu Yanai, Ruka Hishinuma, Reo Yoshikawa
Publikováno v: International Journal of Diabetes in Developing Countries. 35:384-385
Dear Sir, Voglibose, an α-glucosidase inhibitor, lowers the daily glycemic excursions and inhibits overwork of the pancreatic β-cells [1]. Recently, voglibose has been reported to reduce the development of type 2 diabetes in individuals with impair
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::003559bdc6315974fc0fd1e132031d9f
https://doi.org/10.1007/s13410-014-0242-7
Zobrazit plný text záznamu
8
Effects of 6-Month Sitagliptin Treatment on Glucose and Lipid Metabolism, Blood Pressure, Body Weight and Renal Function in Type 2 Diabetic Patients: A Chart-Based Analysis
Autor: Sumie Moriyama, Yoshinori Masui, Akahito Sako, Hidetaka Hamasaki, Hidekatsu Yanai, Shuichi Mishima, Reo Yoshikawa, Hiroki Adachi
Publikováno v: Journal of Clinical Medicine Research
Background: Sitagliptin is one of the dipeptidyl peptidase-4 (DPP-4) inhibitors which prevent the inactivation of incretins, increasing the endogenous active incretin levels. Incretins stimulate insulin secretion from pancreatic β-cells and inhibit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4623abb2434095acfb277e7b767d1d8a
https://doi.org/10.4021/jocmr975w
Zobrazit plný text záznamu
9
Group B streptococcus infection and diabetes: A review
Autor: Shuichi Mishima, Reo Yoshikawa, Hiroki Adachi, Naonori Tsuda, Yoshinori Masui, Hidekatsu Yanai, Hidetaka Hamasaki, Sumie Moriyama
Publikováno v: Journal of Microbiology and Antimicrobials. 4
Streptococcus agalactiae, a group B streptococcus (GBS), has been considered to be a major pathogen in neonates and pregnant women. Recently, there is accumulating concern about its significance for pathogenesis in non-pregnant adult patients. Diabet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d9148afcc5cf31cc7e6c1fccdf6919a
https://doi.org/10.5897/jma11.088
Zobrazit plný text záznamu
10
Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes
Autor: Yoshinori Masui, Hiroshi Kaneko, Junwa Kunimatsu, Reo Yoshikawa, Hidekatsu Yanai
Publikováno v: World Journal of Diabetes. 1:99
The addition of the dipeptidyl peptidase-4 (DDP-4) inhibitor has been reported to achieve greater improvements in glucose metabolism with fewer adverse events compared to increasing the metformin dose in type 2 diabetic patients. We present a patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5d3290f32c2011b5117ee609fce92b4
https://doi.org/10.4239/wjd.v1.i3.99
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje